Literature DB >> 16760259

IFN-gamma and TNF-alpha regulate human NHE3 gene expression by modulating the Sp family transcription factors in human intestinal epithelial cell line C2BBe1.

Md Ruhul Amin1, Jaleh Malakooti, Ricardo Sandoval, Pradeep K Dudeja, Krishnamurthy Ramaswamy.   

Abstract

Diarrhea associated with inflammatory bowel disease has been attributed to stimulated secretion of proinflammatory cytokines like IFN-gamma and TNF-alpha, which have been shown to downregulate the expression of the sodium-hydrogen exchanger-3 (NHE3) gene. In this study, we have investigated the mechanism of NHE3 gene regulation by IFN-gamma and TNF-alpha in C2BBe1 cells. In response to both IFN-gamma (30 ng/ml) and TNF-alpha (20 ng/ml), the construct containing the bp -95 to +5 region of the human NHE3 promoter, which harbors a number of cis-elements including four potential Sp1 binding sites, showed a maximum repression of 60%. Knockdown of Sp1 and Sp3 expression using small interfering RNA resulted in a significant inhibition of the NHE3 promoter activity and resistance to cytokines effects. These cytokines showed no effects on the expression of Sp1 and Sp3 mRNA and protein levels as assessed by RT-PCR and Western blot analyses, respectively. After treatment with cytokines, the binding of Sp1 and Sp3 proteins to NHE3 promoter decreased significantly, as seen by gel mobility shift assays and chromatin immunoprecipitation assays. The inhibitory effects of both cytokines on the NHE3 promoter were completely blocked by the broad-range kinase inhibitor staurosporine and the selective protein kinase A (PKA) inhibitor 8-bromoadenosine-3',5'-cyclic monophosphorothioate, Rp-isomer. The binding affinity of Sp1 and Sp3 proteins for NHE3 Sp1 probe was significantly decreased after in vitro phosphorylation of nuclear proteins by the alpha-catalytic subunit of PKA. Our data indicate that IFN-gamma and TNF-alpha may repress the NHE3 promoter activity in C2BBe1 cells by PKA-mediated phosphorylation of Sp1 and Sp3 transcription factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16760259     DOI: 10.1152/ajpcell.00630.2005

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  39 in total

1.  Tumor necrosis factor-α represses the expression of NHE2 through NF-κB activation in intestinal epithelial cell model, C2BBe1.

Authors:  Md Ruhul Amin; Temitope Orenuga; Sangeeta Tyagi; Pradeep K Dudeja; Krishnamurthy Ramaswamy; Jaleh Malakooti
Journal:  Inflamm Bowel Dis       Date:  2010-08-18       Impact factor: 5.325

2.  Impairment of electroneutral Na+ transport and associated downregulation of NHE3 contributes to the development of diarrhea following in vivo challenge with Brachyspira spp.

Authors:  Cole B Enns; Brandon A Keith; Nitin Challa; John C S Harding; Matthew E Loewen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-11-25       Impact factor: 4.052

3.  Loss of downregulated in adenoma (DRA) impairs mucosal HCO3(-) secretion in murine ileocolonic inflammation.

Authors:  Fang Xiao; Marina Juric; Junhua Li; Brigitte Riederer; Sunil Yeruva; Anurag Kumar Singh; Lifei Zheng; Silke Glage; George Kollias; Pradeep Dudeja; De-An Tian; Gang Xu; Jinxia Zhu; Oliver Bachmann; Ursula Seidler
Journal:  Inflamm Bowel Dis       Date:  2011-05-06       Impact factor: 5.325

4.  Clcn5 knockout mice exhibit novel immunomodulatory effects and are more susceptible to dextran sulfate sodium-induced colitis.

Authors:  Philip Alex; Mei Ye; Nicholas C Zachos; Jennifer Sipes; Thuan Nguyen; Maxim Suhodrev; Liberty Gonzales; Zubin Arora; Ting Zhang; Michael Centola; Sandra E Guggino; Xuhang Li
Journal:  J Immunol       Date:  2010-02-24       Impact factor: 5.422

5.  NHE3 modulates the severity of colitis in IL-10-deficient mice.

Authors:  C B Larmonier; D Laubitz; R D Thurston; A L Bucknam; F M Hill; M Midura-Kiela; R Ramalingam; P R Kiela; F K Ghishan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-03-17       Impact factor: 4.052

6.  Insulin resistance, obesity, hypertension, and renal sodium transport.

Authors:  Shoko Horita; George Seki; Hideomi Yamada; Masashi Suzuki; Kazuhiko Koike; Toshiro Fujita
Journal:  Int J Hypertens       Date:  2011-04-12       Impact factor: 2.420

Review 7.  Transcriptional regulation of the intestinal luminal Na⁺ and Cl⁻ transporters.

Authors:  Jaleh Malakooti; Seema Saksena; Ravinder K Gill; Pradeep K Dudeja
Journal:  Biochem J       Date:  2011-04-15       Impact factor: 3.857

Review 8.  Novel developments in differentiating the role of renal and intestinal sodium hydrogen exchanger 3.

Authors:  Jessica A Dominguez Rieg; Samantha de la Mora Chavez; Timo Rieg
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-10-12       Impact factor: 3.619

9.  Solute carrier family 9, subfamily A, member 3 (SLC9A3)/sodium-hydrogen exchanger member 3 (NHE3) dysregulation and dilated intercellular spaces in patients with eosinophilic esophagitis.

Authors:  Chang Zeng; Simone Vanoni; David Wu; Julie M Caldwell; Justin C Wheeler; Kavisha Arora; Taeko K Noah; Lisa Waggoner; John A Besse; Amnah N Yamani; Jazib Uddin; Mark Rochman; Ting Wen; Mirna Chehade; Margaret H Collins; Vincent A Mukkada; Philip E Putnam; Anjaparavanda P Naren; Marc E Rothenberg; Simon P Hogan
Journal:  J Allergy Clin Immunol       Date:  2018-05-04       Impact factor: 10.793

10.  Restoration of Na+/H+ exchanger NHE3-containing macrocomplexes ameliorates diabetes-associated fluid loss.

Authors:  Peijian He; Luqing Zhao; Lixin Zhu; Edward J Weinman; Roberto De Giorgio; Michael Koval; Shanthi Srinivasan; C Chris Yun
Journal:  J Clin Invest       Date:  2015-08-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.